Literature DB >> 10094447

A detailed analysis of changes in serum C-reactive protein levels in neonates treated for bacterial infection.

S Ehl1, B Gehring, F Pohlandt.   

Abstract

UNLABELLED: A prospective study was undertaken to characterize the rate of increase, time of peak values and rates of decrease in serum concentrations of C-reactive protein (CRP) in a group of infants treated for neonatal bacterial infection. A total of 176 consecutively admitted neonates with birth weight > 1500 g and without mechanical ventilation or central lines in situ, who received antibiotic therapy for suspected bacterial infection, were enrolled. The changes in serum CRP concentration in 60 of 63 infants who had CRP values above 20 mg/l 24-48 h after the beginning of treatment were analysed in detail. Initial increase rates in serum CRP levels of up to 4.5 mg/l per h were documented peak were reached at a mean of 19.5 h after antibiotic therapy had been initiated, but in some patients an increase in serum CRP levels occurred up to 40-48 h after the beginning of treatment. The mean serum half-life of CRP in infected neonates was 21 h (range 11.2-38 h).
CONCLUSION: In neonates with bacterial infection (defined by a combination of clinical signs and increased C-reactive protein and immature-total quotient values) no differences in the overall pattern nor in any of the particular phases of the C-reactive protein response curves could be observed between neonates with positive (n = 13) or negative blood cultures (n = 47).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094447     DOI: 10.1007/s004310051058

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

1.  Lipopolysaccharide binding protein in preterm infants.

Authors:  D Behrendt; J Dembinski; A Heep; P Bartmann
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-11       Impact factor: 5.747

Review 2.  2.5 Million Annual Deaths-Are Neonates in Low- and Middle-Income Countries Too Small to Be Seen? A Bottom-Up Overview on Neonatal Morbi-Mortality.

Authors:  Flavia Rosa-Mangeret; Anne-Caroline Benski; Anne Golaz; Persis Z Zala; Michiko Kyokan; Noémie Wagner; Lulu M Muhe; Riccardo E Pfister
Journal:  Trop Med Infect Dis       Date:  2022-04-21

3.  Targeting C-reactive protein levels using high-dose atorvastatin before coronary artery bypass graft surgery.

Authors:  Norberto Krivoy; Zvi Adler; Ronen Saloma; Ashraf Hawadie; Zaher S Azzam
Journal:  Exp Clin Cardiol       Date:  2008

4.  The effect of acute intermittent hypercapnic hypoxia treatment on IL-6, TNF-alpha, and CRP levels in piglets.

Authors:  Charmaine S Tam; Melanie Wong; Kimberley Tam; Leyla Aouad; Karen A Waters
Journal:  Sleep       Date:  2007-06       Impact factor: 5.849

5.  Validity of serum and urinary hepcidin as biomarkers for late-onset sepsis in premature infants.

Authors:  Hanan Sakr Sherbiny; Hanaa Abdel-El Fattah Mostafa; Laila M Sherief; Naglaa M Kamal; Amal Saeed El-Shal; Mahmoud Mohamed Abdel-El Halm; Hekmat Yaqoub Khan; Al Shaymaa Ahmed Ali
Journal:  Ther Adv Chronic Dis       Date:  2022-09-06       Impact factor: 4.970

6.  C-reactive protein for diagnosing late-onset infection in newborn infants.

Authors:  Jennifer Valeska Elli Brown; Nicholas Meader; Jemma Cleminson; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2019-01-14

7.  Characteristics of neonates with culture-proven bloodstream infection who have low levels of C-reactive protein (≦10 mg/L).

Authors:  Mei-Yin Lai; Ming-Horng Tsai; Chiang-Wen Lee; Ming-Chou Chiang; Reyin Lien; Ren-Huei Fu; Hsuan-Rong Huang; Shih-Ming Chu; Jen-Fu Hsu
Journal:  BMC Infect Dis       Date:  2015-08-11       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.